C12 NBD Globotriaosylceramide (C18:1/12:0)

Formulation: A solid

Formal Name: N-((2S,3R,E)-1-(((2R,3R,4R,5S,6R)-5-(((2S,3R,4R,5R,6R)-3,4-dihydroxy-6-(hydroxymethyl)-5-(((2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)tetrahydro-2H-pyran-2-yl)oxy)-3,4-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)-3-hydroxyoctadec-4-en-2-yl)-12-((7-nitrobenzo[c][1,2,5]oxadiazol-4-yl)amino)dodecanamide

Purity: ≥98%

Formula Markup: C54H91N5O21

Formula Weight: 1146,3

Shelf life (days): 1460

Notes: C12 NBD globotriaosylceramide is a biologically active derivative of globotriaosylceramide that is tagged with a fluorescent C12 nitrobenzoxadiazole (C12 NBD).{39567} C12 NBD globotriaosylceramide accumulates in human umbilical vascular endothelial cells (HUVECs) treated with the α-galactosidase A inhibitor 1-deoxygalactonojirimycin (DGJ; Item No. 17179) in a concentration-dependent manner, an effect that can be reversed by overexpression of α-galactosidase A. As this product is derived from a natural source, there may be variations in the sphingoid backbone. [Matreya, LLC. Catalog No. 1631]

• Artikelnummer: CAY24628-1
• Hersteller: Cayman Chemical
• Hersteller Artikelnummer: 24628-1
• Green Labware: Nein
• Verpackungseinheit: 1 mg
• Mengeneinheit: STK
• Methode: Fluorescence